(Q38031571)

27 August 2017

1 reference

title

Carcinoid syndrome and serotonin: therapeutic effects of ketanserin (English)

1 reference

27 August 2017

1 reference

J I Robertson

1

1 reference

27 August 2017

language of work or name

1 reference

1 January 1990

1 reference

Cardiovascular Drugs and Therapy

27 August 2017

published in

1 reference

27 August 2017

volume

4 Suppl 1

1 reference

27 August 2017

page(s)

53-58

1 reference

Serotonin depletion by fenfluramine in the carcinoid syndrome.

27 August 2017

cites work

1 reference

12 December 2020

The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin

1 reference

12 December 2020

The effect of a serotonin antagonist (UML 491) in carcinoid disease

1 reference

12 December 2020

Infective endocarditis complicating tricuspid valve disease in the carcinoid syndrome

1 reference

12 December 2020

Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin

1 reference

12 December 2020

Carcinoid tumor of the appendix: treatment and prognosis

1 reference

12 December 2020

The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin

1 reference

12 December 2020

Retroperitoneal fibrosis caused by carcinoid tumour

1 reference

12 December 2020

The pentagastrin test in the diagnosis of the carcinoid syndrome

1 reference

12 December 2020

Inhibitory effects of ranitidine on flushing and serum serotonin concentrations in carcinoid syndrome

1 reference

12 December 2020

Free serotonin in human plasma. Quantitative and qualitative estimation

1 reference

12 December 2020

Facial flushing produced in patients with carcinoid syndrome by intravenous adrenaline and noradrenaline

1 reference

12 December 2020

Ketanserin versus placebo in carcinoid syndrome. A clinical controlled trial

1 reference

12 December 2020

Ketanserin in the preoperative and intraoperative management of a patient with carcinoid tumor undergoing tricuspid valve replacement

1 reference

12 December 2020

Effects of Leukocyte Interferon on Clinical Symptoms and Hormone Levels in Patients with Mid-Gut Carcinoid Tumors and Carcinoid Syndrome

1 reference

12 December 2020

5-HT2-receptor blockade in the treatment of heart failure. A preliminary study

1 reference

12 December 2020

Ketanserin, a 5-HT antagonist, in symptomatic treatment of carcinoid syndrome

1 reference

12 December 2020

Peri-operative management of carcinoid syndrome using ketanserin.

1 reference

12 December 2020

Prophylactic use of ketanserin in a patient with carcinoid syndrome

1 reference

12 December 2020

Carcinoid syndrome due to pancreatic-duct neoplasm secreting 5-hydroxytryptophan and 5-hydroxytryptamine

1 reference

12 December 2020

The mechanism of facial flushes in the carcinoid syndrome

1 reference

12 December 2020

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue

1 reference

12 December 2020

Serotonin (5-hydroxytryptamine, 5-HT).

1 reference

12 December 2020

Serotonin and carcinoid tumors

1 reference

12 December 2020

RELEASE OF A KININ PEPTIDE IN THE CARCINOID SYNDROME

1 reference

12 December 2020

Controlling the carcinoid syndrome

1 reference

12 December 2020

Role of hepatic arterial embolisation in the carcinoid syndrome

1 reference

12 December 2020

Carcinoid tumour of the oesophagus: report of a case

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00053427

1 reference

27 August 2017

1 reference